Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells.
Nicola LockwoodSilvia MartiniAinara Lopez-PardoKatharina DeissHendrika A SegerenRobert K SempleIan CollinsDimitra RepanaMathias CobbautTanya N SolimanFrancesca CiccarelliPeter J ParkerPublished in: Cancer research (2022)
The identification of a requirement for p53 in stringent Topo2a-dependent G2 arrest and engagement of PKCε failsafe pathways in arrest-defective hTERT-positive cells provides a therapeutic opportunity to induce selective synthetic lethality.